-
The drug-pricing bill wading through Congress: 3 things to know
For months, legislators have chipped away at President Joe Biden's Build Back Better Act, with the resulting leftovers centering around lowering drug costs for Medicare and Medicaid beneficiaries, according to The Washington Post. -
1 month post-Roe, House passes Right to Contraception Act
About four weeks after the Supreme Court reversed the national right to an abortion, the House passed legislation July 21 to secure the right to contraceptives, according to CNBC. -
Staffing shortage could be hindering controversial Paxlovid clearance
When the FDA declared pharmacists could prescribe Pfizer's antiviral treatment directly to patients in early July, it caused a flurry of mixed reactions among the healthcare industry. The widespread staffing shortage could be halting the process, though. -
World's first malaria vaccine hits financing roadblock
As the World Health Organization continues its rollout of the first authorized malaria vaccine, one of the key investors has pulled out because of the vaccine's low efficacy, according to The Washington Post. -
Tracking each COVID-19 vaccine's journey
Now that Novavax has entered the COVID-19 vaccine scene, here's a rundown of the similarities and differences among each vaccine option, according to Yale Medicine: -
Novavax's COVID-19 vaccine fully authorized
After more than a year of Pfizer, Moderna and Johnson & Johnson shots going into people's arms, there's now a fourth vaccine option. -
Johnson & Johnson's general counsel to retire
The executive vice president and general counsel of Johnson & Johnson, Michael Ullman, MD, plans to retire by the end of 2022 and will be succeeded by Elizabeth Forminard, effective Oct. 17. -
10 hospitals seeking pharmacy leaders
The following 10 hospitals, health systems and hospital operators have posted job listings seeking pharmacy leaders in the last week. -
#BoycottWalgreens trends after alleged birth control dispute
The hashtag "BoycottWalgreens" has flooded social media after a customer took to Twitter earlier this month, alleging a Walgreens worker refused to sell condoms because of religious reasons. -
FDA approves 1st at-home treatment for vitiligo
The FDA granted Incyte, a Wilmington, Del.-based pharmaceutical company, the first approval for a vitiligo treatment after finding positive results in its phase 3 trials July 18. -
Online pharmacy startup launches prescription subscriptions
An online pharmacy that isn't yet a year old introduced a new option for its customers July 18: Pay $10 a month for an unlimited number of prescriptions. -
Novavax approval won't boost vaccination rate, experts say
Though Novavax's COVID-19 vaccine candidate could appeal to those wary of mRNA-based vaccines, don't expect it to spur that much change, health experts told CNBC July 15. -
Despite federal guidance, pharmacists hesitant to fill some orders since Roe
Some pharmacists have been more cautious about filling prescriptions as legal concerns rise for healthcare workers offering reproductive care since the U.S. Supreme Court overturned Roe v. Wade, the Dallas Morning News reported July 18. -
COVID-19 shots for kids lag, prompting concern among health experts
As parents hesitate to inoculate their youngest children and some states are ordering fewer COVID-19 vaccine doses, health experts expressed worry about low vaccination rates, Politico reported July 14. -
Successful Migration to a Vancomycin AUC-dosing Protocol: Evaluation, Implementation and Outcomes in an Acute Care Hospital Setting
Vancomycin, an antibiotic medication used to treat serious bacterial infections, can lead to increased nephrotoxicity without improved efficacy if administered in an excessive dosage, or can fail to achieve the desired therapeutic effect if underdosed. -
High demand for monkeypox vaccine crashes NYC's website for 2nd time
New York City's health department website crashed for the second time because an "overwhelming" number of people tried making appointments for a monkeypox vaccine, according to The Hill. -
FDA authorizes Novavax's COVID-19 vaccine for emergency use
The U.S. is set to soon have a fourth COVID-19 vaccine option after the FDA authorized Novavax's vaccine for emergency use in adults July 13. -
Amid post-Roe chaos, HHS outlines nondiscrimination guidelines for pharmacies
As some hospitals and health systems flounder to care for patients after some states have banned or severely restricted abortions, the HHS instructed national retail pharmacies on July 13 to continue handing out reproductive health medication and other drugs that have been affected by abortion restrictions. -
Prescriptions for mental health medications hiked during COVID-19
Antidepressant prescriptions climbed 8.7 percent since 2019, but some age groups fronted more of the burden, according to The New York Times. -
Teva to fork over $24.8M to settle San Francisco opioid case
Teva Pharmaceuticals will settle a San Francisco lawsuit, which accused the company of fueling the opioid epidemic in the city through the sale of highly addictive painkillers, for $24.8 million to be paid over 13 years, according to a July 12 press release.
Page 46 of 50